{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:50Z","timestamp":1740147350432,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11845-024-03770-x","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T10:02:22Z","timestamp":1725098542000},"page":"2723-2732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of successful secondary hyperparathyroidism treatment on cardiovascular morbidity in patients with chronic kidney disease KDIGO stages G3b-5"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1460-6847","authenticated-orcid":false,"given":"Francesca","family":"Da Canal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"H\u00fcbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran","family":"Mikulicic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny R.","family":"Buechel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"de Rougemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"issue":"9981","key":"3770_CR1","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I et al (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385(9981):1975\u20131982","journal-title":"Lancet"},{"issue":"5","key":"3770_CR2","first-page":"78","volume":"166","author":"NA Samokhvalova","year":"2007","unstructured":"Samokhvalova NA, Romanchishen AF, Gerasimchuk RP, Grinev KM, Zemchenkov A (2007) Secondary hyperparathyroidism: incidence, clinical presentations, treatment. Vestn Khir Im I I Grek 166(5):78\u201381","journal-title":"Vestn Khir Im I I Grek"},{"issue":"12","key":"3770_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1067\/j.cpsurg.2010.08.002","volume":"47","author":"JT Adler","year":"2010","unstructured":"Adler JT, Sippel RS, Chen H (2010) New trends in parathyroid surgery. Curr Probl Surg 47(12):958\u20131017","journal-title":"Curr Probl Surg"},{"issue":"1","key":"3770_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10(1):98\u2013109","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"3770_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.endonu.2015.05.006","volume":"62","author":"JC Bureo","year":"2015","unstructured":"Bureo JC, Arevalo JC, Anton J, Adrados G, Jimenez Morales JL, Robles NR et al (2015) Prevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine. Endocrinol Nutr 62(7):300\u2013305","journal-title":"Endocrinol Nutr"},{"key":"3770_CR6","unstructured":"Massimetti C, Imperato G, Feriozzi S (2019) Correction of secondary hyperparathyroidism with paricalcitol in renal transplant improves left ventricular hypertrophy. G Ital Nefrol 36(1)"},{"issue":"3","key":"3770_CR7","doi-asserted-by":"publisher","first-page":"c257","DOI":"10.1159\/000321867","volume":"118","author":"L Di Lullo","year":"2011","unstructured":"Di Lullo L, Floccari F, Polito P (2011) Right ventricular diastolic function in dialysis patients could be affected by vascular access. Nephron Clin Pract 118(3):c257\u2013c261","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"3770_CR8","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","volume":"65","author":"C Zoccali","year":"2004","unstructured":"Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B et al (2004) Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65(4):1492\u20131498","journal-title":"Kidney Int"},{"issue":"2","key":"3770_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.kint.2017.04.019","volume":"92","author":"C Baigent","year":"2017","unstructured":"Baigent C, Herrington WG, Coresh J, Landray MJ, Levin A, Perkovic V et al (2017) Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 92(2):297\u2013305","journal-title":"Kidney Int"},{"issue":"3","key":"3770_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ki.2014.425","volume":"87","author":"M Ketteler","year":"2015","unstructured":"Ketteler M, Elder GJ, Evenepoel P, Ix JH, Jamal SA, Lafage-Proust MH et al (2015) Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int 87(3):502\u2013528","journal-title":"Kidney Int"},{"issue":"9","key":"3770_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"11","key":"3770_CR12","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1007\/s00330-017-4849-1","volume":"27","author":"OF Clerc","year":"2017","unstructured":"Clerc OF, Kaufmann BP, Possner M, Liga R, Vontobel J, Mikulicic F et al (2017) Long-term prognostic performance of low-dose coronary computed tomography angiography with prospective electrocardiogram triggering. Eur Radiol 27(11):4650\u20134660","journal-title":"Eur Radiol"},{"issue":"4","key":"3770_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15(4):827\u2013832","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3770_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1\u201339 e14","journal-title":"J Am Soc Echocardiogr"},{"issue":"4 Suppl 3","key":"3770_CR15","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1\u2013S201","journal-title":"Am J Kidney Dis"},{"issue":"10053","key":"3770_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1459\u20131544","journal-title":"Lancet"},{"issue":"1","key":"3770_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12968-021-00713-8","volume":"23","author":"H Xu","year":"2021","unstructured":"Xu H, Peng W, Yang Z, Zhang Y, Xia C, Li Z et al (2021) The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping. J Cardiovasc Magn Reson 23(1):23","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1-3","key":"3770_CR18","first-page":"72","volume":"21","author":"S Hara","year":"1995","unstructured":"Hara S, Ubara Y, Arizono K, Ikeguchi H, Katori H, Yamada A et al (1995) Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrolyte Metab 21(1-3):72\u201376","journal-title":"Miner Electrolyte Metab"},{"issue":"3","key":"3770_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ijcard.2003.10.018","volume":"97","author":"AV Mattioli","year":"2004","unstructured":"Mattioli AV, Zennaro M, Bonatti S, Bonetti L, Mattioli G (2004) Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan. Int J Cardiol 97(3):383\u2013388","journal-title":"Int J Cardiol"},{"issue":"7","key":"3770_CR20","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/00004872-200207000-00033","volume":"20","author":"RB Devereux","year":"2002","unstructured":"Devereux RB, Palmieri V, Liu JE, Wachtell K, Bella JN, Boman K et al (2002) Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study. J Hypertens 20(7):1445\u20131450","journal-title":"J Hypertens"},{"issue":"3","key":"3770_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.CIR.89.3.1023","volume":"89","author":"AM Jula","year":"1994","unstructured":"Jula AM, Karanko HM (1994) Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 89(3):1023\u20131031","journal-title":"Circulation"},{"issue":"11","key":"3770_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","volume":"298","author":"BF Culleton","year":"2007","unstructured":"Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR et al (2007) Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298(11):1291\u20131299","journal-title":"JAMA"},{"issue":"6","key":"3770_CR23","first-page":"783","volume":"19","author":"A Covic","year":"2006","unstructured":"Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ (2006) Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation. J Nephrol 19(6):783\u2013793","journal-title":"J Nephrol"},{"issue":"4","key":"3770_CR24","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/ndt\/gfr447","volume":"27","author":"MR Custodio","year":"2012","unstructured":"Custodio MR, Koike MK, Neves KR, dos Reis LM, Graciolli FG, Neves CL et al (2012) Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system. Nephrol Dial Transplant 27(4):1437\u20131445","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"3770_CR25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0008-6363(98)00097-2","volume":"39","author":"KD Schluter","year":"1998","unstructured":"Schluter KD, Piper HM (1998) Left ventricular hypertrophy and parathyroid hormone: a causal connection? Cardiovasc Res 39(2):523\u2013524","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3770_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","volume":"37","author":"KD Schluter","year":"1998","unstructured":"Schluter KD, Piper HM (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37(1):34\u201341","journal-title":"Cardiovasc Res"},{"issue":"11","key":"3770_CR27","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393\u20134408","journal-title":"J Clin Invest"},{"issue":"9","key":"3770_CR28","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1590\/S0100-879X2005000900016","volume":"38","author":"RB Randon","year":"2005","unstructured":"Randon RB, Rohde LE, Comerlato L, Ribeiro JP, Manfro RC (2005) The role of secondary hyperparathyroidism in left ventricular hypertrophy of patients under chronic hemodialysis. Braz J Med Biol Res 38(9):1409\u20131416","journal-title":"Braz J Med Biol Res"},{"issue":"8160","key":"3770_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(80)90602-9","volume":"1","author":"T Drueke","year":"1980","unstructured":"Drueke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C et al (1980) Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet 1(8160):112\u2013114","journal-title":"Lancet"},{"issue":"26","key":"3770_CR30","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"ET Investigators","year":"2012","unstructured":"Investigators ET, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367(26):2482\u20132494","journal-title":"N Engl J Med"},{"issue":"6","key":"3770_CR31","doi-asserted-by":"publisher","first-page":"e001363","DOI":"10.1161\/JAHA.114.001363","volume":"3","author":"DC Wheeler","year":"2014","unstructured":"Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B et al (2014) Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the evaluation of cinacalcet hcl therapy to lower cardiovascular events (EVOLVE) trial. J Am Heart Assoc 3(6):e001363","journal-title":"J Am Heart Assoc"},{"issue":"1-2","key":"3770_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000347145","volume":"122","author":"SR Choi","year":"2012","unstructured":"Choi SR, Lim JH, Kim MY, Hong YA, Chung BH, Chung S et al (2012) Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism. Nephron Clin Pract 122(1-2):1\u20138","journal-title":"Nephron Clin Pract"},{"issue":"11","key":"3770_CR33","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1161\/CIRCRESAHA.120.318556","volume":"128","author":"K Dorr","year":"2021","unstructured":"Dorr K, Kammer M, Reindl-Schwaighofer R, Lorenz M, Prikoszovich T, Marculescu R et al (2021) Randomized trial of etelcalcetide for cardiac hypertrophy in hemodialysis. Circ Res 128(11):1616\u20131625","journal-title":"Circ Res"},{"issue":"7","key":"3770_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H et al (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307(7):674\u2013684","journal-title":"JAMA"},{"issue":"3","key":"3770_CR35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2215\/CJN.03930808","volume":"4","author":"S Mazzaferro","year":"2009","unstructured":"Mazzaferro S, Pasquali M, Taggi F, Baldinelli M, Conte C, Muci ML et al (2009) Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol 4(3):685\u2013690","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"3770_CR36","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1148\/radiology.137.3.7444045","volume":"137","author":"JR Margolis","year":"1980","unstructured":"Margolis JR, Chen JT, Kong Y, Peter RH, Behar VS, Kisslo JA (1980) The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology 137(3):609\u2013616","journal-title":"Radiology"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03770-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03770-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03770-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T23:05:01Z","timestamp":1734995101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03770-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3770"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03770-x","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the cantonal ethic committee of Zurich, BASEC-Nr. 2022-00783. All patients participating in the study signed a general consent form for study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}